211 related articles for article (PubMed ID: 30994510)
1. Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry.
Cortese B; Pellegrini D; Latini RA; Di Palma G; Perotto A; Orrego PS
J Cardiovasc Med (Hagerstown); 2019 Jul; 20(7):471-476. PubMed ID: 30994510
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.
Ali RM; Abdul Kader MASK; Wan Ahmad WA; Ong TK; Liew HB; Omar AF; Mahmood Zuhdi AS; Nuruddin AA; Schnorr B; Scheller B
JACC Cardiovasc Interv; 2019 Mar; 12(6):558-566. PubMed ID: 30898253
[TBL] [Abstract][Full Text] [Related]
3. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes.
Verheye S; Vrolix M; Kumsars I; Erglis A; Sondore D; Agostoni P; Cornelis K; Janssens L; Maeng M; Slagboom T; Amoroso G; Jensen LO; Granada JF; Stella P
JACC Cardiovasc Interv; 2017 Oct; 10(20):2029-2037. PubMed ID: 28964764
[TBL] [Abstract][Full Text] [Related]
4. 6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II Study.
Abizaid A; Carrié D; Frey N; Lutz M; Weber-Albers J; Dudek D; Chevalier B; Weng SC; Costa RA; Anderson J; Stone GW;
JACC Cardiovasc Interv; 2017 Sep; 10(18):1832-1838. PubMed ID: 28935075
[TBL] [Abstract][Full Text] [Related]
5. Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry.
Cortese B; di Palma G; Latini RA; Elwany M; Orrego PS; Seregni RG
Cardiovasc Revasc Med; 2017; 18(7):487-491. PubMed ID: 28365415
[TBL] [Abstract][Full Text] [Related]
6. A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-Month data from the Nanoluté Registry.
Dani S; Shah D; Sojitra P; Parikh K; Shetty R; di Palma G; Cortese B
Cardiovasc Revasc Med; 2019 Mar; 20(3):235-240. PubMed ID: 30196029
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolutè study.
El-Mokdad R; di Palma G; Cortese B
Catheter Cardiovasc Interv; 2020 Nov; 96(5):E496-E500. PubMed ID: 32191384
[TBL] [Abstract][Full Text] [Related]
8. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
[TBL] [Abstract][Full Text] [Related]
9. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold.
Chevalier B; Abizaid A; Carrié D; Frey N; Lutz M; Weber-Albers J; Dudek D; Weng SC; Akodad M; Anderson J; Stone GW
Circ Cardiovasc Interv; 2019 Jun; 12(6):e007283. PubMed ID: 31177821
[TBL] [Abstract][Full Text] [Related]
11. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
[TBL] [Abstract][Full Text] [Related]
12. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon.
Ahmad WAW; Nuruddin AA; Abdul Kader MASK; Ong TK; Liew HB; Ali RM; Mahmood Zuhdi AS; Ismail MD; Yusof AKM; Schwenke C; Kutschera M; Scheller B
JACC Cardiovasc Interv; 2022 Apr; 15(7):770-779. PubMed ID: 35305906
[TBL] [Abstract][Full Text] [Related]
14. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.
Tang Y; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Tian J; Guan C; Xu B; Gao R;
JACC Cardiovasc Interv; 2018 Dec; 11(23):2381-2392. PubMed ID: 30522667
[TBL] [Abstract][Full Text] [Related]
15. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY).
Kang WC; Park SM; Jang AY; Oh PC; Shin ES; Yu CW; Oh SJ; Kim YH; Won H; Lee SR; Lee SY; Hong YJ; Lee SY; Kim BO; Kim SW;
Angiology; 2021 Nov; 72(10):986-993. PubMed ID: 33982603
[TBL] [Abstract][Full Text] [Related]
17. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
18. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
